Evommune, Inc. - EVMN

Sector: Healthcare · Industry: Pharmaceutical Preparations

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q2 2026 · Q1 2026

Value (USD)

Total reported value ($000)

$526.7M

QoQ value delta ($000)

-$266.6M (-33.61%)

Implied price effect (QoQ)

-39.32%

Total shares

37,831,414

QoQ shares delta

+3,254,675 (+9.41%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q2 2026 data: 107 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
EQT Fund Management S.a r.l.	70,281	5,288,313	8.15%
RA CAPITAL MANAGEMENT, L.P.	46,443	3,494,638	0.4%
SymBiosis Capital Partners, LLC	29,445	1,280,778	55.8%
PRICE T ROWE ASSOCIATES INC /MD/	25,796	1,940,939	0.0%
Pivotal bioVenture Partners Investment Advisor LLC	25,609	1,926,943	8.32%
JPMORGAN CHASE & CO	23,374	1,553,132	0.0%
JANUS HENDERSON GROUP PLC	20,615	896,700	0.01%
RTW INVESTMENTS, LP	19,964	1,502,235	0.17%
Nan Fung Group Holdings Ltd	19,151	1,441,032	14.56%
Point72 Asset Management, L.P.	19,071	1,435,049	0.02%
Andera Partners	18,499	1,391,990	8.96%
EVENTIDE ASSET MANAGEMENT, LLC	16,069	1,209,129	0.21%
Vestal Point Capital, LP	13,290	1,000,000	0.31%
Jupiter Topco LLC	11,917	896,700	0.0%
BlackRock, Inc.	11,782	886,538	0.0%
VANGUARD CAPITAL MANAGEMENT LLC	11,720	881,895	0.0%
BAKER BROS. ADVISORS LP	11,261	847,390	0.06%
Defilade Capital Management, L.P.	10,540	793,145	1.41%
AMERICAN CENTURY COMPANIES INC	10,034	755,018	0.0%
Alyeska Investment Group, L.P.	9,361	704,425	0.02%
BALYASNY ASSET MANAGEMENT L.P.	8,333	627,015	0.01%
Affinity Asset Advisors, LLC	6,646	500,100	0.3%
Velan Capital Investment Management LP	5,997	451,255	3.65%
UBS Group AG	5,496	413,553	0.0%
FEDERATED HERMES, INC.	4,319	325,000	0.01%